6-(1,3-benzothiazol-6-yl)-2-methyl-N-[1-[3-(6-piperazin-1-yl-3-pyridinyl)phenyl]ethyl]pyrimidin-4-amine
C29H29N7S — CID 70977639
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(1,3-benzothiazol-6-yl)-2-methyl-N-[1-[3-(6-piperazin-1-yl-3-pyridinyl)phenyl]ethyl]pyrimidin-4-amine
6-(1,3-benzothiazol-6-yl)-2-methyl-N-[1-[3-(6-piperazin-1-yl-3-pyridinyl)phenyl]ethyl]pyrimidin-4-amine (PubChem CID 70977639) has the molecular formula C29H29N7S and a molecular weight of 507.67 g/mol. Its IUPAC name is 6-(1,3-benzothiazol-6-yl)-2-methyl-N-[1-[3-(6-piperazin-1-yl-3-pyridinyl)phenyl]ethyl]pyrimidin-4-amine.
Molecular Properties
| Compound Name | 6-(1,3-benzothiazol-6-yl)-2-methyl-N-[1-[3-(6-piperazin-1-yl-3-pyridinyl)phenyl]ethyl]pyrimidin-4-amine |
|---|---|
| PubChem CID | 70977639 |
| Molecular Formula | C29H29N7S |
| Molecular Weight | 507.67 g/mol |
| Exact Mass | 507.22 |
| IUPAC Name | 6-(1,3-benzothiazol-6-yl)-2-methyl-N-[1-[3-(6-piperazin-1-yl-3-pyridinyl)phenyl]ethyl]pyrimidin-4-amine |
| SMILES | Cc1nc(NC(C)c2cccc(-c3ccc(N4CCNCC4)nc3)c2)cc(-c2ccc3ncsc3c2)n1 |
| InChI | InChI=1S/C29H29N7S/c1-19(33-28-16-26(34-20(2)35-28)23-6-8-25-27(15-23)37-18-32-25)21-4-3-5-22(14-21)24-7-9-29(31-17-24)36-12-10-30-11-13-36/h3-9,14-19,30H,10-13H2,1-2H3,(H,33,34,35) |
| InChIKey | GXIQTOFJWLRYOF-UHFFFAOYSA-N |
| XLogP | 5.71 |
| TPSA | 78.86 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 507.67 |
| LogP ≤ 5 | 5.71 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 70977639 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.